Effect of Chorionicity on Umbilical Cord Blood Acid-Base Analysis of the Second Twin.


Journal

Twin research and human genetics : the official journal of the International Society for Twin Studies
ISSN: 1832-4274
Titre abrégé: Twin Res Hum Genet
Pays: England
ID NLM: 101244624

Informations de publication

Date de publication:
06 2020
Historique:
pubmed: 7 4 2020
medline: 6 5 2021
entrez: 7 4 2020
Statut: ppublish

Résumé

Our objective was to determine whether chorionicity affects umbilical cord blood acid-base parameters of the second twin. This was a retrospective cohort of twin pregnancies delivered at ≥23 weeks of gestation at a tertiary hospital from 2010 to 2016. Patients were included if arterial and venous umbilical cord gas results were available for both newborns and chorionicity was confirmed histologically. Exclusion criteria included intrauterine fetal demise of either twin prior to labor, major fetal anomalies, monoamnionicity, uncertain chronicity and twin-to-twin transfusion syndrome. The primary outcome evaluated was the umbilical artery (UA) pH of the second twin. A total of 593 dichorionic (DC) and 86 monochorionic (MC) twin pregnancies were included. No difference in UA pH was observed between MC and DC twins. Among vaginal deliveries (n = 97), the UA pH of the first twin was higher than the second twin (7.26 vs. 7.24; p = .01). Twin-to-twin delivery interval (TTDI) ≥20 min was associated with a higher UA pH in the first twin compared to the second twin (7.25 vs. 7.16, respectively; p = .006). Multivariable logistic regression was used to predict arterial pH < 7.20 for the second twin; the most predictive factors were arterial pH < 7.20 for the first twin, chronic hypertension and prolonged TTDI. Chorionicity was not associated with any acid-base parameter of umbilical cord blood in either the first or second twin. No differences in neonatal outcomes were observed based on chorionicity or birth order. Populations with a lower cesarean delivery rate may yield different findings.

Identifiants

pubmed: 32248867
pii: S1832427420000109
doi: 10.1017/thg.2020.10
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

178-183

Auteurs

Matthew J Blitz (MJ)

Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Southside Hospital, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Bay Shore, NY, USA.

Burton Rochelson (B)

Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Southside Hospital, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Bay Shore, NY, USA.

Nontawan Benja-Athonsirikul (N)

Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, North Shore University Hospital, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, NY, USA.
Department of Obstetrics and Gynecology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, NY, USA.

Weiwei Shan (W)

Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, North Shore University Hospital, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, NY, USA.
Department of Obstetrics and Gynecology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, NY, USA.
Biostatistics Unit, Feinstein Institute for Medical Research, Manhasset, NY, USA.

Meir Greenberg (M)

Department of Obstetrics and Gynecology, Division of Medical Informatics, North Shore University Hospital, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, NY, USA.

Luis A Bracero (LA)

Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Southside Hospital, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Bay Shore, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH